Angiotensin AT 2 receptors: Cardiovascular hope or hype?

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 809-824

  Widdop, Robert E ^a   Jones, Emma S ^a   Hannan, Ruth E ^a   Gaspari, Tracey A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; AT 2 receptor; Blood pressure; Cardiac and vascular remodelling; Fibrosis; Vasodilatation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTISENSE OLIGONUCLEOTIDE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; GUANOSINE PHOSPHATE; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SARALASIN; VALSARTAN; VASODILATOR AGENT; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

ANGIOGENESIS; AUTORADIOGRAPHY; BINDING SITE; CARDIOVASCULAR SYSTEM; ESSENTIAL HYPERTENSION; HEART; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; KIDNEY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RENOVASCULAR HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SODIUM DEPLETION; SODIUM EXCRETION; TISSUE DISTRIBUTION; URINARY EXCRETION; VASCULAR FIBROSIS; WOUND HEALING; ANIMAL; CARDIOVASCULAR FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; VASODILATATION;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 2; TETRAZOLES; VALINE; VASODILATION;

EID: 0345304290     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705448     Document Type: Review

References (196)

1. AKISHITA, M., HORIUCHI, M., YAMADA, H., ZHANG, L., SHIRAKAMI, G., TAMURA, K., OUCHI, Y. & DZAU, V.J. (2000a). Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol. Genomics, 2, 13-20.
2. AKISHITA, M., ITO, M., LEHTONEN, J.Y., DAVIET, L., DZAU, V.J. & HORIUCHI, M. (1999). Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J. Clin. Invest., 103, 63-71.
3. AKISHITA, M., IWAI, M., WU, L., ZHANG, L., OUCHI, Y., DZAU, V.J. & HORIUCHI, M. (2000b). Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation, 102, 1684-1689.
4. ARIMA, S., ENDO, Y., YAOITA, H., OMATA, K., OGAWA, S., TSUNODA, K., ABE, M., TAKEUCHI, K., ABE, K. & ITO, S. (1997). Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest., 100, 2816-2823.
5. ASANO, K., DUTCHER, D.L., PORT, J.D., MINOBE, W.A., TREMMEL, K.D., RODEN, R.L., BOHLMEYER, T.J., BUSH, E.W., JENKIN, M.J., ABRAHAM, W.T., RAYNOLDS, M.V., ZISMAN, L.S., PERRYMAN, M.B. & BRISTOW, M.R. (1997). Selective down-regulation of the angiotensin II AT1-receptor subtype in fatting human ventricular myocardium. Circulation, 95, 1193-1200.
6. BAKER, K.M., BOOZ, G.W. & DOSTAL, D.E. (1992). Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Ann. Rev. Physiol., 54, 227-241.
7. BARBER, M.N., SAMPEY, D.B. & WIDDOP, R.E. (1999). AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension, 34, 1112-1116.
8. BARTUNEK, J., WEINBERG, E.O., TAJIMA, M., ROHRBACH, S. & LORELL, B.H. (1999). Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts. Circulation, 99, 22-25.
9. BAUTISTA, R., SANCHEZ, A., HERNANDEZ, J., OYEKAN, A. & ESCALANTE, B. (2001). Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension, 38, 669-673.
10. BEDECS, K., ELBAZ, N., SUTREN, M., MASSON, M., SUSINI, C., STROSBERG, A.D. & NAHMIAS, C. (1997). Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J., 325, 449-454.
11. BONNET, F., COOPER, M.E., CAREY, R.M., CASLEY, D. & CAO, Z. (2001). Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens., 19, 1075-1081.
12. BOOZ, G.W. & BAKER, K.M. (1996). Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension, 28, 635-640.
13. BOTTARI, S.P., KING, I.N., REICHLIN, S., DAHLSTROEM, I., LYDON, N. & DE GASPARO, M. (1992). The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem. Biophys. Res., Commun., 183, 206-211.
14. BRECHLER, V., REICHLIN, S., DE GASPARO, M. & BOTTARI, S.P. (1994). Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism. Receptors Channels, 2, 89-98.
15. BREDE, M., HADAMEK, K., MEINEL, L., WIESMANN, F., PETERS, J., ENGELHARDT, S., SIMM, A., HAASE, A., LOHSE, M.J. & HEIN, L. (2001). Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation, 104, 2602-2607.
16. BRINK, M., ERNE, P., DE GASPARO, M., ROGG, H., SCHMID, A., STULZ, P. & BULLOCK, G. (1996). Localization of the angiotensin II receptor subtypes in the human atrium. J. Mol. Cell Cardiol., 28, 1789-1799.
17. BUISSON, B., LAFLAMME, L., BOTTARI, S.P., DE GASPARO, M., GALLO-PAYET, N. & PAYET, M.D. (1995). A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J. Biol. Chem., 270, 1670-1674.
18. BURRELL, J.H. & LUMBERS, E.R. (1997). Angiotensin receptor subtypes in the uterine artery during ovine pregnancy. Eur. J. Pharmacol., 330, 257-267.
19. BUSCHE, S., GALLINAT, S., BOHLE, R.M., REINECKE, A., SEEBECK, J., FRANKE, F., FINK, L., ZHU, M., SUMNERS, C. & UNGER, T. (2000). Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am. J. Pathol., 157, 605-611.
20. CAO, Z., BONNET, F., CANDIDO, R., NESTEROFF, S.P., BURNS, W.C., KAWACHI, H., SHIMIZU, F., CAREY, R.M., DE GASPARO, M. & COOPER, M.E. (2002). Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J. Am. Soc. Nephrol., 13, 1773-1787.
21. CAO, Z., DEAN, R., WU, L., CASLEY, D. & COOPER, M.E. (1999). Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension, 34, 408-414.
22. CAO, Z., KELLY, D.J., COX, A., CASLEY, D., FORBES, J.M., MARTINELLO, P., DEAN, R., GILBERT, R.E. & COOPER, M.E. (2000). Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int., 58, 2437-2451.
23. CAPUTO, L., BENESSIANO, J., BOULANGER, C.M. & LEVY, B.I. (1995). Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arterioscler. Thromb. Vasc. Biol., 15, 1646-1651.
24. CAREY, R.M., HOWELL, N.L., JIN, X.H. & SIRAGY, H.M. (2001a). Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension, 38, 1272-1277.
25. CAREY, R.M., JIN, X.H. & SIRAGY, H.M. (2001b). Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am. J. Hypertens., 14, 98S-102S.
26. CEILER, D.L., NELISSEN-VRANCKEN, H.J., DEMEY, J.G. & SMITS, J.F. (1998). Effect of chronic blockade of angiotensin II-receptor subtypes on aortic compliance in rats with myocardial infarction. J. Cardiovasc. Pharmacol., 31, 630-637.
27. CHAKI, S. & INAGAMI, T. (1993). New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol. Pharmacol., 43, 603-608.
28. CHANG, R.S. & LOTTI, V.J. (1991). Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci., 49, 1485-1490.
29. CIUFFO, G.M., VISWANATHAN, M., SELTZER, A.M., TSUTSUMI, K. & SAAVEDRA, J.M. (1993). Glomerular angiotensin II receptor subtypes during development of rat kidney. Am. J. Physiol., 265, F264-F271.
30. COLLISTER, J.P., SOUCHERAY, S.L. & OSBORN, J.W. (2002). Chronic hypotensive effects of losartan are not dependent on the actions of angiotensin II at AT2 receptors. J. Cardiovasc. Pharmacol., 39, 107-116.
31. COX, D.A. & COHEN, M.L. (1996). Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol. Rev., 48, 3-19.
32. CUI, T., NAKAGAMI, H., IWAI, M., TAKEDA, Y., SHIUCHI, T., DAVIET, L., NAHMIAS, C. & HORIUCHI, M. (2001). Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc. Res., 49, 863-871.
33. DAUGHERTY, A., MANNING, M.W. & CASSIS, L.A. (2001). Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol., 134, 865-870.
34. DE GASPARO, M., CATT, K.J., INAGAMI I WRIGHT, J.W. & UNGER, T.H. (2000). International Union of Pharmacology. XXIII. The Angiotensin II Receptors. Pharmacol. Rev., 52, 415-472.
35. DE GASPARO, M. & SIRAGY, H.M. (1999). The AT2 receptor: fact, fancy and fantasy. Regul. Peptides, 81, 11-24.
36. DE PAOLIS, P., PORCELLINI, A., GIGANTE, B., GILIBERTI, R., LOMBARDI, A., SAVOIA, C., RUBATTU, S. & VOLPE, M. (1999). Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells. J. Hypertens., 17, 1873-1877.
37. DICKSTEIN, K. & KJEKSHUS, J. (1999). Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Am. J. Cardiol., 83, 477-481.
38. DIEP, Q.N., LI, J.S. & SCHIFFRIN, E.L. (1999). In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension, 34, 617-624.
39. DIMITROPOULOU, C., WHITE, R.E., FUCHS, L., ZHANG, H., CATRAVAS, J.D. & CARRIER, G.O. (2001). Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension., 37, 301-307.
40. DIMMELER, S., RIPPMANN, V., WEILAND, U., HAENDELER, J. & ZEIHER, A.M. (1997). Angiotensin II induces apoptosis of human endothelial cells* Protective effect of nitric oxide. Circ. Res., 81, 970-976.
41. DUDLEY, D.T., HUBBELL, S.E. & SUMMERFELT, R.M. (1991). Characterization of angiotensin II (AT2) binding sites in R3T3 cells. Mol. Pharmacol., 40, 360-367.
42. DUDLEY, D.T. & SUMMERFELT, R.M. (1993). Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells. Regul. Peptides, 44, 199-206.
43. DUFF, J.L., MARRERO, M.B., PAXTON, W.G., CHARLES, C.H., LAU, L.F., BERNSTEIN, K.E. & BERK, B.C. (1993). Angiotensin II induces 3CH134, a protein-tyrosin phosphatase, in vascular smooth muscle cells. J. Biol. Chem., 268, 26037-26040.
44. DUKE, L.M., EPPEL, G.A., WIDDOP, R.E. & EVANS, R.G. (2003). Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits. Hypertension, 42, 200-205.
45. ENDO, Y., ARIMA, S., YAOITA, H., OMATA, K., TSUNODA, K., TAKEUCHI, K., ABE, K. & ITO, S. (1997). Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int. Suppl., 63, S205-S207.
46. ENDO, Y., ARIMA, S., YAOITA, H., TSUNODA, K., OMATA, K. & ITO, S. (1998). Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J. Vasc. Res., 35, 421-427.
47. FISCHER, J.W., STOLL M HAHN, A.W. & UNGER, T. (2001). Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc. Res., 51, 784-791.
48. FISCHER, T.A., SINGH, K., O'HARA, D.S., KAYE, D.M. & KELLY, R.A. (1998). Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. Am. J. Physiol., 275, H906-H916.
49. GALLINAT, S., BUSCHE, S., RAIZADA, M.K. & SUMNERS, C. (2000). The angiotensin II type 2 receptor: an enigma with multiple variations. Am. J. Physiol. Endocrinol. Metab., 278, E357-E374.
50. GIGANTE, B., PIRAS, O., DE PAOLIS, P., PORCELLINI, A., NATALE, A. & VOLPE, M. (1998). Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. J. Hypertens., 16, 2039-2043.
51. GIGANTE, B., RUBATTU, S., RUSSO, R., PORCELLINI, A., ENEA, I., DE PAOLIS, P., SAVOIA, C., NATALE, A., PIRAS, O. & VOLPE, M. (1997). Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors. Hypertension, 30, 563-568.
52. GOETTE, A., ARNDT, M., ROCKEN, C., SPIESS, A., STAACK, T., GELLER, J.C., HUTH, C., ANSORGE, S., KLEIN, H.U. & LENDECKEL, U. (2000). Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation, 101, 2678-2681.
53. GOHLKE, P., PEES, C. & UNGER, T. (1998). AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension, 31, 349-355.
54. GOLDFARB, D.A., DIZ, D.I., TUBBS, R.R., FERRARIO, C.M. & NOVICK, A.C. (1994). Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J. Urol., 151, 208-213.
55. GOTO, M., MUKOYAMA, M., SUGAWARA, A., SUGANAMI, T., KASAHARA, M., YAHATA, K., MAKINO, H., SUGA, S., TANAKA, I. & NAKAO, K. (2002). Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens. Res., 25, 125-133.
56. GRONE, H.J., SIMON, M. & FUCHS, E. (1992). Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney. Am. J. Physiol., 262, F326-F331.
57. GROSS, V., SCHUNCK, W.H., HONECK, H., MILIA, A.F., KARGEL, E., WALTHER, T., BADER, M., INAGAMI, T., SCHNEIDER, W. & LUFT, F.C. (2000). Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int., 57, 191-202.
58. HABERL, R.L. (1994). Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke, 25, 1476-1479 discussion 1480.
59. HANNAN, R.E., DAVIS, E.A. & WIDDOP, R.E. (2003a). Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br. J. Pharmacol., in press..
60. HANNAN, R.E., GASPARI, T.A., DAVIS, E.A. & WIDDOP, R.E. (2003b). Differential regulation by AT1 and AT2 receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta. Hypertension, submitted..
61. HAYWOOD, G.A., GULLESTAD, L., KATSUYA, T., HUTCHINSON, H.G., PRATT, R.E., HORIUCHI, M. & FOWLER, M.B. (1997). AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation, 95, 1201-1206.
62. HEIN, L., BARSH, G.S., PRATT, R.E., DZAU, V.J. & KOBILKA, B.K. (1995). Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice [published erratum appears in Nature 1996; 380(6572):366]. Nature, 377, 744-747.
63. HENRION, D., KUBIS, N. & LEVY, B.I. (2001). Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension., 38, 1150-1157.
64. HORIUCHI, M., AKISHITA, M. & DZAU, V.J. (1999a). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension, 33, 613-621.
65. HORIUCHI, M., HAYASHIDA, W., AKISHITA, M., TAMURA, K., DAVIET, L., LEHTONEN, J.Y. & DZAU, V.J. (1999b). Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ. Res., 84, 876-882.
66. HORIUCHI, M., HAYASHIDA, W., KAMBE, T., YAMADA, T. & DZAU, V.J. (1997). Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem., 272, 19022-19026.
67. HUANG, X.C., RICHARDS, E.M. & SUMNERS, C. (1995). Angiotensin II type 2 receptor-mediated stimulation of protein phosphatase 2A in rat hypothalamic/brainstem neuronal cocultures. J. Neurochem., 65, 2131-2137.
68. HUANG, X.C., RICHARDS, E.M. & SUMNERS, C. (1996). Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J. Biol. Chem., 271, 15635-15641.
69. ICHIHARA, S., SENBONMATSU, T., PRICE Jr, E., ICHIKI, T., GAFFNEY, F.A. & INAGAMI, T. (2001). Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation, 104, 346-351.
70. ICHIHARA, S., SENBONMATSU, T., PRICE Jr, E., ICHIKI, T., GAFFNEY, F.A. & INAGAMI, T. (2002). Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation, 106, 2244-2249.
71. ICHIKI, T., LABOSKY, P.A., SHIOTA, C., OKUYAMA, S., IMAGAWA, Y., FOGO, A., NIIMURA, F., ICHIKAWA, I., HOGAN, B.L. & INAGAMI, T. (1995). Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature, 377, 748-750.
72. INAGAMI, T. & SENBONMATSU, T. (2001). Dual effects of angiotensin II type 2 receptor on cardiovascular hypertrophy. Trends Cardiovasc. Med., 11, 324-328.
73. JALOWY, A., SCHULZ, R., DORGE, H., BEHRENDS, M. & HEUSCH, G. (1998). Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J. Am. Coll. Cardiol., 32, 1787-1796.
74. JANIAK, P., PILLON, A., PROST, J.F. & VILAINE, J.P. (1992). Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension, 20, 737-745.
75. JIN, X.Q., FUKUDA, N., SU, J.Z., LAI, Y.M., SUZUKI, R., TAHIRA, Y., TAKAGI, H., IKEDA, Y., KANMATSUSE, K. & MIYAZAKI, H. (2002). Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension, 39, 1021-1027.
76. 1 receptor antagonists in salt-restricted rats? Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 6, 84.
77. JONG, P., DEMERS, C., MCKELVIE, R.S. & LIU, P.P. (2002). Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol., 39, 463-470.
78. KATADA, J. & MAJIMA, M. (2002). AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions, [comment]. Br. J. Pharmacol., 136, 484-491.
79. KIMURA, B., SUMNERS, C. & PHILLIPS, M.I. (1992). Changes in skin angiotensin II receptors in rats during wound healing. Biochem. Biophys. Res. Commun., 187, 1083-1090.
80. KURISU, S., OZONO, R., OSHIMA, T., KAMBE, M., ISHIDA, T., SUGINO, H., MATSUURA, H., CHAYAMA, K., TERANISHI, Y., IBA, O., AMANO, K. & MATSUBARA, H. (2003). Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertens., 41, 99-107.
81. LAFLAMME, L., DE GASPARO, M., GALLO, J.M., PAYET, M.D. & GALLO-PAYET, N. (1996). Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J. Biol. Chem., 271, 22729-22935.
82. LAMBERS, D.S., GREENBERG, S.G. & CLARK, K.E. (2002). Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep. Am. J. Physiol., 278, H353-H359.
83. LEHTONEN, J.Y., DAVIET, L., NAHMIAS, C., HORIUCHI, M. & DZAU, V.J. (1999). Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol. Endocrinol., 13, 1051-1060.
84. LEVY, B.I., BENESSIANO, J., HENRION, D., CAPUTO, L., HEYMES, C., DURIEZ, M., POITEVIN, P. & SAMUEL, J.L. (1996). Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest., 98, 418-425.
85. LI, J.S., TOUYZ, R.M. & SCHIFFRIN, E.L. (1998). Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension, 31, 487-492.
86. LI, X.C. & WIDDOP, R.E. (2003). AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br. J. Pharmacol., submitted..
87. LIU, K.L., LO, M., GROUZMANN, E., MUTTER, M. & SASSARD, J. (1999). The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys. Br. J. Pharmacol., 126, 826-832.
88. LIU, Y.H., YANG, X.P., SHAROV, V.G., NASS, O., SABBAH, H.N., PETERSON, E. & CARRETERO, O.A. (1997). Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure* Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest., 99, 1926-1935.
89. LO, M., LIU, K.L., LANTELME, P. & SASSARD, J. (1995). Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J. Clin. Invest., 95, 1394-1397.
90. LOPEZ, J.J., LORELL, B.H., INGELFINGER, J.R., WEINBERG, E.O., SCHUNKERT, H., DIAMANT, D. & TANG, S.S. (1994). Distribution and function of cardiac angiotensin AT1-and AT2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol., 267, H844-H852.
91. LUCIUS, R., GALLINAT, S., ROSENSTIEL, P., HERDEGEN, T., SIEVERS, J. & UNGER, T. (1998). The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med., 188, 661-670.
92. MA, J., NISHIMURA, H., FOGO, A., KON, V., INAGAMI, T. & ICHIKAWA, I. (1998). Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int., 53, 937-944.
93. MAKINO, N., SUGANO, M., OHTSUKA, S., SAWADA, S. & HATA, T. (1999). Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc. Res., 44, 543-548.
94. MAKINO, N., SUGANO, M., OTSUKA, S. & HATA, T. (1997). Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension, 30, 796-802.
95. MARRERO, M.B., SCHIEFFER, B., PAXTON, W.G., HEERDT, L., BERK, B.C., DELAFONTAINE, P. & BERNSTEIN, K.E. (1995). Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature, 375, 247-250.
96. MASAKI, H., KURIHARA, T., YAMAKI, A., INOMATA, N., NOZAWA, Y., MORI, Y., MURASAWA, S., KIZIMA, K., MARUYAMA, K., HORIUCHI, M., DZAU, V.J., TAKAHASHI, H., IWASAKA, T., INADA, M. & MATSUBARA, H. (1998). Cardiac-specific over-expression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest., 101, 527-535.
97. MATROUGUI, K., LEVY, B.I. & HENRION, D. (2000). Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br. J. Pharmacol., 130, 521-526.
98. MATROUGUI, K., LOUFRANI, L., HEYMES, C., LEVY, B.I. & HENRION, D. (1999). Activation of AT(2) receptors by endogenous angiotensin II is involved inflow-induced dilation in rat resistance arteries. Hypertension, 34, 659-665.
99. MATSUBARA, H. (1998). Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res., 83, 1182-1191.
100. MATSUMOTO, T., OZONO, R., OSHIMA, T., MATSUURA, H., SUEDA, T., KAJIYAMA, G. & KAMBE, M. (2000). Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc. Res., 46, 73-81.
101. MCMULLEN, J.R., GIBSON, K.J., LUMBERS, E.R. & BURRELL, J.H. (2001). Selective down-regulation of AT2 receptors in uterine arteries from pregnant ewes given 24-h intravenous infusions of angiotensin II. Regul. Peptides, 99, 119-129.
102. MCMULLEN, J.R., GIBSON, K.J., LUMBERS, E.R., BURRELL, J.H. & WU, J. (1999). Interactions between AT1 and AT2 receptors in uterine arteries from pregnant ewes. Eur. J. Pharmacol., 378, 195-202.
103. MEFFERT, S., STOLL, M., STECKELINGS, U.M., BOTTARI, S.P. & UNGER, T. (1996). The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell Endocrinol., 122, 59-67.
104. MIFUNE, M., SASAMURA, H., SHIMIZU-HIROTA, R., MIYAZAKI, H. & SARUTA, T. (2000). Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension, 36, 845-850.
105. MIYATA, T.V., PARK, F., LI, X.F. & COWLEY Jr, A.W. (1999). Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am. J. Physiol., 277, F437-F446.
106. MOORE, A.F., HEIDERSTADT, N.T., HUANG, E., HOWELL, N.L., WANG, Z.Q., SIRAGY, H.M. & CAREY, R.M. (2001). Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension, 37, 1285-1291.
107. MORRISSEY, J.J. & KLAHR, S. (1999). Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am. J. Physiol., 276, F39-F45.
108. MUNOZ-GARCIA, R., MAESO, R., RODRIGO, E., NAVARRO, J., RUILOPE, L.M., CASAL, M.C., CACHOFEIRO, V. & LAHERA, V. (1995). Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide. J. Hypertens., 13, 1779-1784.
109. MUNZENMAIER, D.H. & GREENE, A.S. (1996). Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension, 27, 760-765.
110. NAHMIAS, C., CAZAUBON, S.M., BRIEND-SUTREN, M.M., LAZARD, D., VILLAGEOIS, P. & STROSBERG, A.D. (1995). Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells. Biochem. J., 306, 87-92.
111. NAKAJIMA, M., HUTCHINSON, H.G., FUJINAGA, M., HAYASHIDA, W., MORISHITA, R., ZHANG, L., HORIUCHI, M., PRATT, R.E. & DZAU, V.J. (1995). The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Nat. Acad. Sci. U.S.A., 92, 10663-10667.
112. NIO, Y., MATSUBARA, H., MURASAWA, S., KANASAKI, M. & INADA, M. (1995). Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest., 95, 46-54.
113. NORA, E.H., MUNZENMAIER, D.H., HANSEN-SMITH, F.M., LOMBARD, J.H. & GREENE, A.S. (1998). Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am. J. Physiol., 275, H1395-H1403.
114. OHKUBO, N., MATSUBARA, H., NOZAWA, Y., MORI, Y., MURASAWA, S., KIJIMA, K., MARUYAMA, K., MASAKI, H., TSUTUMI, Y., SHIBAZAKI, Y., IWASAKA, T. & INADA, M. (1997). Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation, 96, 3954-3962.
115. OISHI, Y., OZONO, R., YANO, Y., TERANISHI, Y., AKISHITA, M., HORIUCHI, M., OSHIMA, T. & KAMBE, M. (2003). Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension, 41, 814-818.
116. OPIE, L.H. & SACK, M.N. (2001). Enhanced angiotensin II activity in heart failure: revaluation of the counterregulatory hypothesis of receptor subtypes. Circ. Res., 88, 654-658.
117. OTSUKA, S., SUGANO, M., MAKINO, N., SAWADA, S., HATA, T. & NIHO, Y. (1998). Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension, 32, 467-472.
118. OZAWA, Y., SUZUKI, Y., MURAKAMI, K. & MIYAZAKI, H. (1996). The angiotensin II type 2 receptor primarily inhibits cell growth via pertussis toxin-sensitive G proteins. Biochem. Biophys. Res. Commun., 228, 328-333.
119. OZONO, R., WANG, Z.Q., MOORE, A.F., INAGAMI, T., SIRAGY, H.M. & CAREY, R.M. (1997). Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension, 30, 1238-1246.
120. PEES, C., UNGER, T. & GOHLKE, P. (2003). Effect of angiotensin AT(2) receptor stimulation on vascular cyclic GMP production in normotensive Wistar-Kyoto rats. Int. J. Biochem. Cell Biol., 35, 963-972.
121. PFEFFER, M.A., MCMURRAY, J., LEIZOROVICZ, A., MAGGIONI, A.P., ROULEAU, J.L., VAN DE WERF, F., HENIS, M., NEUHART, E., GALLO, P., EDWARDS, S., SELLERS, M.A., VELAZQUEZ, E. & CALIFF, R. (2000). Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am. Heart J., 140, 727-750.
122. PHOON, S. & HOWES, L.G. (2002). Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)-receptors. J. Renin Angiotensin Aldosterone Syst., 3, 36-39.
123. PHOON, S. & HOWES, L.G. (2001). Role of angiotensin type 2 receptors in human forearm vascular responses of normal volunteers. Clin. Exp. Pharmacol. Physiol., 28, 734-736.
124. PUEYO, M.E., ARNAL, J.F., RAMI, J. & MICHEL, J.B. (1998). Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am. J. Physiol., 274, C214-C220.
125. REGITZ-ZAGROSEK, V., FRIEDEL, N., HEYMANN, A., BAUER, P., NEUSS, M., ROLFS, A., STEFFEN, C., HILDEBRANDT, A., HETZER, R. & FLECK, E. (1995). Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation, 91, 1461-1471.
126. ROGG, H., DE GASPARO, M., GRAEDEL, E., STULZ, P., BURKART, F., EBERHARD, M. & ERNE, P. (1996). Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur. Heart J., 17, 1112-1120.
127. ROULSTON, C.L., LAWRENCE, A.J., JARROTT, B. & WIDDOP, R.E. (2003). Localization of AT(2) receptors in the nucleus of the solitary tract of spontaneously hypertensive and Wistar Kyoto rats using [1251] CGP42112: upregulation of a non-angiotensin II binding site following unilateral nodose ganglionectomy. Brain Res., 968, 139-155.
128. RUIZ-ORTEGA, M., LORENZO, O., RUPEREZ, M., ESTEBAN, V., SUZUKI, Y., MEZZANO, S., PLAZA, J.J. & EGIDO, J. (2001). Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension, 38, 1382-1387.
129. RUIZ-ORTEGA, M., LORENZO, O., RUPEREZ, M., KONIG, S., WITTIG, B. & EGIDO, J. (2000). Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ. Res., 86, 1266-1272.
130. SABRI, A., LEVY, B.I., POITEVIN, P., CAPUTO, L., FAGGIN, E., MAROTTE, F., RAPPAPORT, L. & SAMUEL, J.L. (1997). Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler. Thromb. Vasc. Biol., 17, 257-264.
131. SAITO, S., HIRATA, Y., EMORI, T., IMAI, T. & MARUMO, F. (1996). Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens. Res. Clin. Exp., 19, 201-206.
132. SCHEUER, D.A. & PERRONE, M.H. (1993). Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol., 264, R917-R923.
133. SCHNEIDER, M.D. & LORELL, B.H. (2001). AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation, 104, 247-248.
134. SCHUIJT, M.P., BASDEW, M., VAN VEGHEL, R., DE VRIES, R., SAXENA, P.R., SCHOEMAKER, R.G. & DANSER, A.H. (2001). AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am. J. Physiol. - Heart Circ. Physiol., 281, H2590-H2596.
135. SCHUIJT, M.P., DE VRIES, R., SAXENA, P.R. & DANSER, A.M. (1999). No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats. J. Hypertens., 17, 1879-1884.
136. SECHI, L.A., GRADY, E.F., GRIFFIN, C.A., KALINYAK, J.E. & SCHAMBELAN, M. (1992a). Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol., 262, F236-F240.
137. SECHI, L.A., GRIFFIN, C.A., GRADY, E.F., KALINYAK, J.E. & SCHAMBELAN, M. (1992b). Characterization of angiotensin II receptor subtypes in rat heart. Circ. Res., 71, 1482-1489.
138. SENBONMATSU, T., ICHIHARA, S., PRICE JR, E., GAFFNEY, F.A. & INAGAMI, T. (2000), Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest., 106, R25-R29.
139. SEYEDI, N., XU, X., NASJLETTI, A. & HINTZE, T.H. (1995). Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension, 26, 164-170.
140. SHANMUGAM, S., LLORENS-CORTES, C., CLAUSER, E., CORVOL, P. & GASC, J.M. (1995). Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am. J. Physiol., 268, F922-F930.
141. SHARMA, D., BUYSE, M., PITT, B. & RUCINSKA, E.J. (2000). Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am. J. Cardiol., 85, 187-192.
142. SHENOY, U.V., RICHARDS, E.M., HUANG, X.C. & SUMNERS, C. (1999). Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology, 140, 500-509.
143. SHIBASAKI, Y., MATSUBARA, H., NOZAWA, Y., MORI, Y., MASAKI, H., KOSAKI, A., TSUTSUMI, Y., UCHIYAMA, Y., FUJIYAMA, S., NOSE, A., IBA, O., TATEISHI, E., HASEGAWA, T., HORIUCHI, M., NAHMIAS, C. & IWASAKA, T. (2001). Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase. Hypertension, 38, 367-372.
144. SIRAGY, H.M. (2002). Angiotensin receptor blockers: how important is selectivity? Am. J. Hypertens., 15, 1006-1014.
145. SIRAGY, H.M. & CAREY, R.M. (1996). The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats [see comments]. J. Clin. Invest., 97, 1978-1982.
146. SIRAGY, H.M. & CAREY, R.M. (1997). The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest., 100, 264-269.
147. SIRAGY, H.M. & CAREY, R.M. (1999). Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension, 33, 1237-1242.
148. SIRAGY, H.M. & CAREY, R.M. (2001). Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Curr. Opin. Nephrol. Hypertens., 10, 99-103.
149. SIRAGY, H.M., DE GASPARO, M. & CAREY, R.M. (2000). Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension, 35, 1074-1077.
150. SIRAGY, H.M., DE GASPARO, M., EL-KERSH, M. & CAREY, R.M. (2001). Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP. Hypertension, 38, 183-186.
151. SIRAGY, H.M., EL-KERSH, M.A., DE GASPARO, M., WEBB, R.L. & CAREY, R.M. (2002). Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. J. Hypertens., 20, 1157-1163.
152. SIRAGY, H.M., INAGAMI, T., ICHIKI, T. & CAREY, R.M. (1999a). Sustained hypersensitivtiy to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc. Nat. Acad. Sci. U.S.A., 96, 6506-6510.
153. SIRAGY, H.M., JAFFA, A.A. & MARGOLIUS, H.S. (1997). Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension, 29, 757-762.
154. SIRAGY, H.M., JAFFA, A.A., MARGOLIUS, H.S. & CAREY, R.M. (1996). Renin-angiotensin system modulates renal bradykinin production. Am. J. Physiol., 271, R1090-R1095.
155. SIRAGY, H.M., SENBONMATSU, T., ICHIKI, T., INAGAMI, T. & CAREY, R.M. (1999b). Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J. Clin. Invest., 104, 181-188.
156. SR-LOUIS, J., SICOTTE, B., BEDARD, S. & BROCHU, M. (2001). Blockade of angiotensin receptor subtypes in arcuate uterine artery of pregnant and postpartum rats. Hypertension., 38, 1017-1023.
157. STOLL, M., STECKELINGS, U.M., PAUL, M., BOTTARI, S.P., METZGER, R. & UNGER, T. (1995). The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest., 95, 651-657.
158. STROTH, U., BLUME, A., MIELKE, K. & UNGER, T. (2000). Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells. Mol. Brain Res., 78, 175-180.
159. SU, J.Z., FUKUDA, N., JIN, X.Q., LAI, Y.M., SUZUKI, R., TAHIRA, Y., TAKAGI, H., IKEDA, Y., KANMATSUSE, K. & MIYAZAKI, H. (2002). Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR. Hypertension, 40, 853-858.
160. SUGINO, H., OZONO, R., KURISU, S., MATSUURA, H., ISHIDA, M., OSHIMA, T., KAMBE, M., teranishi, Y., masaki, H. & matsubara, H. (2001). Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice. Hypertension, 37, 1394-1398.
161. SUZUKI, J., IWAI, M., NAKAGAMI, H., WU, L., CHEN, R., SUGAYA, T., HAMADA, M., HIWADA, K. & HORIUCHI, M. (2002). Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation, 106, 847-853.
162. SUZUKI, J., MATSUBARA, H., URAKAMI, M. & INADA, M. (1993). Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ. Res., 73, 439-447.
163. TANAKA, M., TSUCHIDA, S., IMAI, T., FUJII, N., MIYAZAKI, H., ICHIKI, T., NARUSE, M. & INAGAMI, T. (1999). Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem. Biophys. Res. Commun., 258, 194-198.
164. TEA, B.S., DER SARKISSIAN, S., TOUYZ, R.M., HAMET, P. & DEBLOIS, D. (2000). Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension, 35, 1069-1073.
165. THORUP, C., KORNFELD, M., GOLIGORSKY, M.S. & MOORE, L.C. (1999). AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries. J. Am. Soc. Nephrol., 10, S220-S224.
166. THORUP, C., KORNFELD, M., WINAVER, J.M., GOLIGORSKY, M.S. & MOORE, L.C. (1998). Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Archiv. - Eur. J. Physiol., 435, 432-434.
167. TOUYZ, R.M., ENDEMANN, D., HE, G., LI, J.S. & SCHIFFRIN, E.L. (1999). Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension, 33, 366-372.
168. TSUTSUMI, Y., MATSUBARA, H., MASAKI, H., KURIHARA, H., MURASAWA, S., TAKAI, S., MIYAZAKI, M., NOZAWA, Y., OZONO, R., NAKAGAWA, K., MIWA, T., KAWADA, N., MORI, Y., SHIBASAKI, Y., TANAKA, Y., FUJIYAMA, S., KOYAMA, Y., FUJIYAMA, A., TAKAHASHI, H. & IWASAKA, T. (1999). Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest., 104, 925-935.
169. TSUTSUMI, Y., MATSUBARA, H., OHKUBO, N., MORI, Y., NOZAWA, Y., MURASAWA, S., KIJIMA, K., MARUYAMA, K., MASAKI, H., MORIGUCHI, Y., SHIBASAKI, Y., KAMIHATA, H., INADA, M. & IWASAKA, T. (1998). Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ. Res., 83, 1035-1046.
170. TSUZUKI, S., EGUCHI, S. & INAGAMI, T. (1996a). Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT2) receptor in R3T3 cells. Biochem. Biophys. Res. Commun., 228, 825-830.
171. TSUZUKI, S., MATOBA, T., EGUCHI, S. & INAGAMI, T. (1996b). Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension, 28, 916-918.
172. UNGER, T. (1999). The angiotensin type 2 receptor: variations on an enigmatic theme. J. Hypertens., 17, 1775-1786.
173. VAN KESTEREN, C.A., VAN HEUGTEN, H.A., LAMERS, J.M., SAXENA, P.R., SCHALEKAMP, M.A. & DANSER, A.H. (1997). Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J. Mol. Cell. Cardiol., 29, 2147-2157.
174. VARAGIC, J., SUSIC, D. & FROHLICH, E.D. (2001). Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors. Hypertension, 37, 1399-1403.
175. VISWANATHAN, M. & SAAVEDRA, J.M. (1992). Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides, 13, 783-786.
176. VISWANATHAN, M., TSUTSUMI, K., CORREA, F.M. & SAAVEDRA, J.M. (1991). Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Communi., 179, 1361-1367.
177. WANG, Z.Q., MILLATT, L.J., HEIDERSTADT, N.T., SIRAGY, H.M., JOHNS, R.A. & CAREY, R.M. (1999). Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension, 33, 96-101.
178. WANG, Z.Q., MOORE, A.F., OZONO, R., SIRAGY, H.M. & CAREY, R.M. (1998). Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension, 32, 78-83.
179. WHARTON, J., MORGAN, K., RUTHERFORD, R.A., CATRAVAS, J.D., CHESTER, A., WHITEHEAD, B.F., DELEVAL, M.R., YACOUB, M.H. & POLAK, J.M. (1998). Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J. Pharmacol. Exp. Therapeutics, 284, 323-336.
180. WIDDOP, R.E., GARDINER, S.M., KEMP, P.A. & BENNETT, T. (1992). Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174. Bri. J. Pharmacol., 107, 873-880.
181. WIDDOP, R.E., MATROUGUI, K., LEVY, B.I. & HENRION, D. (2002). AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension, 40, 516-520.
182. WIEMER, G., SCHOLKENS, B.A., BUSSE, R., WAGNER, A., HEITSCH, H. & LINZ, W. (1993). The functional role of angiotensin II-subtype AT2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm. Pharmacol. Lett., 3, 24-27.
183. WOLF, G., WENZEL, U., BURNS, K.D., HARRIS, R.C., STAHL, R.A. & THAISS, F. (2002). Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int., 61, 1986-1995.
184. WONG, P.C., CHRIST, D.D. & TIMMERMANS, P.B. (1992). Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats. Eur. J. Pharmacol., 220, 267-270.
185. WU, L., IWAI, M., NAKAGAMI, H., CHEN, R., SUZUKI, J., AKISHITA, M., DE GASPARO, M. & HORIUCHI, M. (2002). Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arteriosclerosis, Thrombosis Vasc. Biol., 22, 49-54.
186. WU, L., IWAI, M., NAKAGAMI, H., LI, Z., CHEN, R., SUZUKI, J., AKISHITA, M., DE GASPARO, M. & HORIUCHI, M. (2001). Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation., 104, 2716-2721.
187. XU, J., CARRETERO, O.A., LIU, Y.H., SHESELY, E.G., YANG, F., KAPKE, A. & YANG, X.P. (2002). Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension, 40, 244-250.
188. XU, Y., CLANACHAN, A.S. & JUGDUTT, B.I. (2000). Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension, 36, 506-510.
189. YAMADA, T., AKISHITA, M., POLLMAN, M.J., GIBBONS, G.H., DZAU, V.J. & HORIUCHI, M. (1998). Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci., 63, L289-4295.
190. YAMADA, T., HORIUCHI, M. & DZAU, V.J. (1996). Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. U.S.A., 93, 156-160.
191. YANG, Z., BOVE, C.M., FRENCH, B.A., EPSTEIN, F.H., BERR, S.S., DIMARIA, J.M., GIBSON, J.J., CAREY, R.M. & KRAMER, C.M. (2002). Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation, 106, 106-111.
192. ZARAHN, E.D., YE, X., ADES, A.M., REAGAN, L.P. & FLUHARTY, S.J. (1992). Angiotensin-induced cyclic GMP production is mediated by multiple receptor subtypes and nitric oxide in N1E-115 neuroblastoma cells. J. Neurochem., 58, 1960-1963.
193. ZHAO, Y., BIERMANN, T., LUTHER, C., UNGER, T., CULMAN, J. & GOHLKE, P. (2003). Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J. Neurochem., 85, 759-767.
194. ZHUO, J., ALLEN, A.M., ALCORN, D., ALDRED, G.P., MACGREGOR, D.P. & MENDELSOHN, F.A. (1995). The distribution of angiotensin II receptors. In: Hypertension: Pathophysiology, Diagnosis and Management, ed. Laragh, J.H. & Brenner, B.M. pp. 1739-1762. New York: Raven Press, Ltd..
195. ZHUO, J., DEAN, R., MACGREGOR, D., ALCORN, D. & MENDELSOHN, F.A. (1996). Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin. Exp. Pharmacol. Physiol. - Suppl., 3, S147-8154.
196. ZWART, A.S., DAVIS, E.A. & WIDDOP, R.E. (1998). Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors. Br. J. Pharmacol., 125, 1429-1436.